Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β- estradiol valerate and cyproterone acetate or medroxyprogesterone acetate

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 388-394

  Imthurn, Bruno ^a   Rosselli, Marinella ^a   Jaeger, Adrian W ^b   Keller, Paul J ^a   Dubey, Raghvendra K ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Schering (Schweiz) AG   (Switzerland)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; ESTRADIOL VALERATE; MEDROXYPROGESTERONE ACETATE; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; OVARY INSUFFICIENCY; POSTMENOPAUSE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIPOPROTEINS, LDL; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; POSTMENOPAUSE;

EID: 0031024335     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.388     Document Type: Article

References (35)

1. Wenger NK, Speroff L, Packard B. 1993 Cardiovascular health and disease in women. N Engl J Med. 329:247-256.
2. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. 1989 Menopause and risk factors for coronary heart disease. N Engl J Med. 321:641-646.
3. Nabulsi AA, Folsom AR, White A, et al. 1993 Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 328:1069-1075.
4. Adams MR, Kaplan JR, Manuck SB, et al. 1990 Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 10:1051-1057.
5. Moncada S, Palmer RM, Higgs EA. 1991 Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:109-142.
6. Dubey RK. 1994 Vasodilator-derived nitric oxide inhibits angiotensin-II and fetal calf serum-induced growth of arteriolar smooth muscle cells. J Pharmacol Exp Therap. 269:402-408.
7. 1 receptors. J Clin Invest. 96:141-149.
8. 1 receptors. J Clin Invest. 96:141-149.
9. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. 1994 Induction of constitutive nitric oxide synthase by estradiol in human endothelial cells. Hypertension. 24:386 (Abstract 83).
10. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. 1992 Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA. 89:11259-11263.
11. Van-Buren GA, Yang DS, Clark KE. 1992 Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 167:828-833.
12. Rosselli M, Imthurn B, Macas E, Keller PJ, Dubey RK. 1994 Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO-release. Biochem Biophys Res Commun. 202:1543-1552.
13. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. 1995 Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. A two year follow-up study. Hypertension. 25:848-853.
14. Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. 1987 Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 327:237-239.
15. Chin JH, Azhar S, Hoffman BB. 1992 Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest. 89:10-18.
16. Stevenson JC, Crook D, Gogsland IF. 1993 Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 98:83-90.
17. Kushwaha RS, Lewis DS, Carey KD, McGill, Jr, HC. 1991 Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp). Arterioscler Thromb. 11:23-31.
18. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 325:1196-1204.
19. Burstein M, Scholnick HR, Morfin R. 1970 Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 11:583-595.
20. Friedewald WT, Levy RI, Fredrickson DS. 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499-502.
21. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. 1977 Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 23:882-884.
22. Dusterberg B, Nishino Y. 1982 Pharmacokinetics and pharmacological features of ocstradiol valerate. Maturitas. 4:315-324.
23. Ochoa JB, Udekwu AO, Billiar TR, et al. 1991 Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 214:621-626.
24. Shultz PJ, Tolins JP. 1993 Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin Invest. 91:642-650.
25. Hibbs JB, Westenfelder C, Taintor R, et al. 1992 Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest. 89:867-877.
26. Wasserman AE. 1978 The nitrite-nitrosamine situation: a review. Food Engineering. 50:110-116.
27. Evans TG, Ramussen K, Wiebke G, Hibbs, Jr, JB. 1994 Nitric oxide synthesis in patients with advanced HIV infection. Clin Exp Immunol. 97:83-86.
28. Sack MN, Rader DJ, Cannon RO. 1994 Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343:269-270.
29. Bush TL, Barrett-Connor E, Cowan LD, et al. 1987 Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation. 75:1102-1109.
30. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. 1994 Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Nat Acad Sci USA. 91:5212-5216.
31. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. 1994 Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 89:1501-1510.
32. Rosser M, Chorich L, Howard E, Zamorano P, Mahesh VB. 1993 Changes in rat uterine receptor messenger ribonucleic acid levels during estrogen and progesterone induced estrogen receptor depletion and subsequent replenishment. Biol Reprod. 48:89-98.
33. Lobo RA. 1992 The role of progestins in hormone replacement therapy. Am J Obstet Gynecol. 166:1997-2004.
34. Wolinsky H. 1972 Effects of estrogen and progesterone treatment on the response of the aorta of male rats to hypertension. Morphological and chemical studies. Circ Res. 30:341-349.
35. Miller VM, Vanhoutte PM. 1991 Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 261: R1022-R1027.